UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

Journal of clinical oncology, 2015-09, Vol.33 (26), p.2848-2856

2015

Volltextzugriff (PDF)

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2019-01, Vol.37 (3), p.190-201

2019

Volltextzugriff (PDF)

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4708-4713

2008

Volltextzugriff (PDF)

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5474-5483

2005

Volltextzugriff (PDF)

Gene Expression–Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma

Journal of clinical oncology, 2013-02, Vol.31 (6), p.692-700

2013

Volltextzugriff (PDF)

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5578-5587

2005

Volltextzugriff (PDF)

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1668-1677

2017

Volltextzugriff (PDF)

Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer

Journal of clinical oncology, 2003-01, Vol.21 (1), p.123-128

2003

Volltextzugriff (PDF)

Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4474-4485

2004

Volltextzugriff (PDF)

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Journal of clinical oncology, 2003-11, Vol.21 (21), p.4016-4026

2003

Volltextzugriff (PDF)

Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4973-4980

2008

Volltextzugriff (PDF)

Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer

Journal of clinical oncology, 2003-01, Vol.21 (2), p.320-326

2003

Volltextzugriff (PDF)

High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3438-3444

2006

Volltextzugriff (PDF)

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2664-2672

2003

Volltextzugriff (PDF)

How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?

Journal of clinical oncology, 2000-02, Vol.18 (4), p.877-884

2000

Volltextzugriff (PDF)

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1561-1567

1998

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Study of the Combination of Docetaxel and Topotecan in Patients With Solid Tumors

Journal of clinical oncology, 2000-09, Vol.18 (18), p.3288-3294

2000

Volltextzugriff (PDF)

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2715-2721

1998

Volltextzugriff (PDF)

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Journal of clinical oncology, 1999-03, Vol.17 (3), p.880-886

1999

Volltextzugriff (PDF)

Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease

Journal of clinical oncology, 1995-04, Vol.13 (4), p.876-883

1995

Volltextzugriff (PDF)

Radiation Therapy With Concomitant Hydroxyurea and Fluorouracil in Stage II and III Head and Neck Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.638-644

1999

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionIEEE/IET Electronic Library

KollektionJournals@Ovid Complete

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(21)
Oncology
(21)
Science & Technology
(21)
Adult
(20)
Male
(20)
Aged
(19)
Female
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Aged, 80 And Over
(10)
Antineoplastic Agents
(10)
Pharmacology. Drug Treatments
(10)
Tumors
(9)
Treatment Outcome
(8)
Chemotherapy
(6)
Drug Administration Schedule
(6)
Fluorouracil - Administration & Dosage
(6)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Gene Expression–Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer

Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens

Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer

High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

Pharmacokinetic and Pharmacodynamic Study of the Combination of Docetaxel and Topotecan in Patients With Solid Tumors

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease

Radiation Therapy With Concomitant Hydroxyurea and Fluorouracil in Stage II and III Head and Neck Cancer

Aktive Filter

Suchergebnisse filtern